GSK Investigational Site

Middleton, Wisconsin 53562-2215

0 studies enrolling now · 7 studies all time

What they study most

Alzheimer's Disease, Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), Migraine Disorders, Post-Traumatic Stress Disorder

Studies at this site

• Seasonal Affective Depression (SAD) Study — Completed
• A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder — Stopped early
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed
• Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder — Completed
• Sexual Functioning Study With Antidepressants — Completed
• Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed
• Migraine Study in Adolescent Patients — Completed